The authors describe a case of an undetectable everolimus level in a patient with kidney cancer who received phenobarbital and was hospitalized because of heart failure.

Hematology oncology pharmacists should be aware of this rare and potentially devastating complication of temozolomide therapy.

To our knowledge, cases of successful treatment of chronic myeloid leukemia (CML) with low-dose nilotinib (Tasigna) have not been reported. The following case represents our experience with a patient with CML who achieved good response to nilotinib therapy.
To our knowledge, cases of successful treatment of chronic myeloid leukemia (CML) with low-dose nilotinib (Tasigna) have not been reported. The following case represents our experience with a patient with CML who achieved good response to nilotinib therapy.

Results 1 - 4 of 4